Search PubMedSearch

Biomedical subjects

M M Bryant

Publications and source records attributed to M M Bryant.

4 recordsLinked to original sources

Age at sexual maturity influences the response of single comb White Leghorn pullets to marginal and low levels of dietary phosphorus.

This study was designed to determine the differences in response of early-maturing (EM) and late-maturing (LM) Single Comb White Leghorn pullets within a flock to marginal or low dietary phosphorus. Various levels of dietary phosphorus were fed to EM and LM Leghorn pullets from 18 wk of age until the age of peak egg production (24 wk). The dietary phosphorus levels were 0.40, 0.45, 0.50, 0.55 and 0.70 g total phosphorus (tP)/100 g diet, corresponding to calculated available phosphorus values of 0.18, 0.23, 0.28, 0.33 and 0.48 g/100 g, respectively. At 0.70 and 0.55 g tP/100 g, the plasma inorganic phosphorus, Ca++ and urine calcium concentrations did not differ between EM and LM pullets, whereas LM pullets had a better bone status than EM pullets as reflected by bone mineral content, bone density and bone breaking strength. As dietary phosphorus was lowered from 0.55 to 0.4 g tP/100 g, the plasma concentration of inorganic phosphorus dropped and that of Ca++ increased at greater rates in LM pullets than in EM pullets. The magnitude of decline in bone status was also greater in LM than in EM pullets when dietary phosphorus was lowered from 0.55 to 0.40 g tP/100 g. The maximum incidences of osteoporosis and mortality were observed in LM pullets fed 0.40 g tP/100 g followed by LM pullets fed 0.45 g tP/100 g diet. We conclude that when early layer diets contain marginal or low levels of phosphorus, the severity of adverse effects are greater in LM pullets than in EM pullets.

Aging

Absorption of silicon and aluminum by hens fed sodium zeolite A with various levels of dietary cholecalciferol.

Two experiments were conducted to determine whether 1) serum Si and Al is increased in hens intubated with sodium zeolite A (SZA); and 2) dietary cholecalciferol (vitamin D3) influences the absorption of Si or Al by hens fed SZA. In Experiment 1, hens were intubated at oviposition with 0, 1, or 2 g of SZA. Blood samples were collected from the brachial vein at oviposition, and 4, 8, 12, 16, and 20 h postoviposition. Serum samples were analyzed for Si and Al. Peak serum Si and Al were observed at 4 and 8 h postoviposition, respectively. In Experiment 2, hens consumed commercial layer diets ad libitum containing five levels of dietary cholecalciferol (100 to 500 IU/kg) with or without .75% SZA for 6 wk. Blood samples were collected at the end of the 6-wk period by cardiac puncture at oviposition. When dietary cholecalciferol was increased from 100 to 200 IU/kg of diet there was an increase (P < .05) in serum Si but not Al. Levels of cholecalciferol above 200 IU/kg did not produce an additional increase in serum Si. The results showed increased (P < .01) serum concentrations of Si and Al for hens intubated with or fed SZA. It was concluded that Si and Al from SZA are absorbed by commercial Leghorn hens, and a possible involvement of Si or Al should be considered in the mechanism of action of SZA associated with improved eggshell quality and bone development.

Absorption

Sample size required for various methods of assessing bone status in commercial leghorn hens.

A study was conducted to determine the appropriate sample size required for various methods used to assess tibial bone status in commercial Leghorn hens. The methods used were in vivo bone mineral content (BMC), in vivo bone density (BD), in vitro BMC, in vitro BD, tibia bone breaking strength (TBS), and percentage bone ash (BA). Dietary total P levels of .4, .45, .5, .55, and .7% were used as treatment source of variation. Twenty hens were sampled randomly to represent each dietary treatment. The CV for each bone status comparison method was estimated and was used in a procedure to estimate the sample size requirement for detecting a difference of delta between treatments. The sample size required to detect the difference between treatment means varied depending on 1) the method used to compare bone status 2) the difference between the treatment means to be detected as significant (delta); and 3) the level of significance (alpha) assumed. The sample size required for various methods are tabulated at .01, .05, and .1 level of significance and for 2.5, 5,7.5, 10, 15, and 20% delta. To detect an actual difference of 5% from the mean to be significant, at the .05 level of significance, a sample size of 44, 22, 31, 23, 47, and 85 hens per treatment would be necessary for in vivo BMC, in vivo BD, in vitro BMC, in vitro BD, TBS, and BA methods, respectively. The estimated sample size values would help researchers in designing experiments that involve bone status comparison of commercial Leghorn hens.

Animals